Disappointed

Americans United for Life Disappointed by Oklahoma Governor's Veto of Bill Banning Destructive Embryo Research

OKLAHOMA CITY, April 23 /PRNewswire-USNewswire/ -- Last night, Oklahoma Governor Brad Henry vetoed Oklahoma House Bill 1326, a bill making it illegal for any Oklahoma business to conduct research that would kill a human embryo or subject an unborn child to a substantial risk of death or injury. T...

AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill

Bipartisan Package Would Have Improved Benefits for Prevention, Mental Health and Low-Income Programs, Boosted Quality through National E-Prescribing CHICAGO, June 12 /PRNewswire-USNewswire/ -- Today a minority of the U.S. Senate blocked critical legislation to protect and improve Medicare f...

AARP Disappointed in Senate's Inability to Pass Health Care Reform

WASHINGTON, Jan. 28 /PRNewswire-USNewswire/ -- AARP CEO Bill Novelli made the following statement about today's vote against the health care reform bill, AB1X 1 (Nunez & Perata) by the California State Senate Committee on Health: "Today, the California State Senate failed to seize an oppo...

Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents

National survey finds parents worried about an unhappy child on Christmas morning, want advice on keeping family harmony CINCINNATI, Dec. 6 /PRNewswire/ -- As they're searching the web for information about recalled toys and scanning store shelves for toys they think are safe, now p...

Catholic Health Association Disappointed by Failure to Override SCHIP Veto

Delay Jeopardizes Health Insurance For Low-Income Children WASHINGTON, Oct. 18 /PRNewswire-USNewswire/ -- Sister Carol Keehan, DC, president and chief executive officer of the Catholic Health Association of the United States (CHA), issued the following statement. The Catholic Health Associ...

Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed

Poor aesthetic outcome after lumpectomy linked to depression, fear, study finds WEDNESDAY, July 9 (HealthDay News) -- A third of women who opt for breast-conserving cancer surgery say they now have an asymmetry between their breasts that greatly affects their quality of life, a new stu...

ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride

...te and discussion regarding a serious public health issue," said Vincent J. Milano, ViroPharma's president and chief executive officer. "While we're disappointed with the vote, we hope that the OGD will take every precaution to ensure that CDI patients will be treated with truly bioequivalent versions of vancom...

Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction

...Federal District Court challenging the proposed acquisition. "We are disappointed by the Federal Trade Commission's decision to seek to enjoin the transactio...Thoratec is not in the best interests of our shareholders. While we too are disappointed with the decision by the FTC, we are, nonetheless, excited about HeartWare'...

Clinical Trial by Licensee Does Not Meet Primary Endpoint

...ug, dirucotide, if it reaches the market. Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "We are obviously disappointed by the results and look forward to further announcements from BioMS and Lilly regarding their future plans for this approach to treating SPMS." ...

NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors

...thank Bruce for all his contributions to NeurogesX during the initial regulatory approval and E.U. partnership discussions surrounding Qutenza. We are disappointed in his resignation but certainly understand the rationale and wish him well in his future endeavors." Following Mr. Peacock's departure Neuro...

Disappointed in Medical Technology

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

...e president of Lilly Research Laboratories. "We look forward to further conversations with BioMS Medical about this project." "We are obviously disappointed by this result and will be working closely with our clinical team to evaluate these data and the available data from MAESTRO-02 and MAESTRO-03 to dete...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

...ar rates of complete response but no increased benefit in overall survival, compared to those who received induction chemotherapy alone. "We are disappointed that this study with lestaurtinib did not demonstrate a benefit for this patient population but we remain committed to oncology clinical research and ...

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction

...formulate future development plans. Patrick J. McEnany, Catalyst's Chairman, President and Chief Executive Officer, commented, "We are obviously disappointed in the cocaine trial results, given the positive results of three prior human trials and numerous animal studies; however, we are not ready to abandon...

Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint

...ight have on other ongoing Nexavar melanoma trials. Data from this study are expected to be presented at an upcoming scientific meeting. "We're disappointed with the results of the study and that the therapy did not bring benefit to patients with melanoma, a historically difficult tumor to treat," said Tod...

Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients

...vudine was licensed from Bukwang Pharmaceuticals of South Korea, where the drug is marketed under the trade name Levovir. "While we are obviously disappointed with the outcome, we believe the decision to stop dosing is an appropriate one," stated Schaefer Price, President and Chief Executive Officer. "Our fu...

Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis

...ome between the two treatment groups as measured on the modified Rankin scale of disability, the primary endpoint of the study. "We are deeply disappointed that Viprinex did not improve overall patient outcomes in our clinical study," said Paul E. Freiman, president and chief executive officer. "This news...

Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia

...ared to placebo. Arena is finishing a complete analysis of the data, but does not anticipate any further development of APD125. "While we are disappointed and anticipated a different result based on objective polysomnographic results from our previous studies, our priority remains the successful developm...

AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia

...erms of the parties' collaboration agreement, AstraZeneca has agreed to make a $2.0 million milestone payment to Targacept. "We are obviously disappointed that AZD3480 did not meet our goals in the HALO trial," commented J. Donald deBethizy, Ph.D., President and Chief Executive Officer of Targacept. "We ...

Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

...cines Agency (EMEA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), as well as motesanib clinical investigators. "While we are disappointed in this outcome, it is consistent with data seen with some other anti-VEGF therapies and appears to constitute a class effect of these types of agents...

Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig

...ced that it has engaged Mufson Howe Hunter & Company LLC to investigate possible strategic alternatives to maximize shareholder value. "While we are disappointed we could not reach a final agreement on the acquisition at this time, in light of the strong strategic and cultural fit between Encorium and Prologue ...

Disappointed in Biological News

Obama Budget Level Funds Career Technical Education

...onal Board reports. "It is refreshing that this Administration recognizes the need for an investment in career technical education, however I am disappointed that the President's budget proposes flat funding for Perkins," said Kimberly A. Green, executive director of the National Association of State Direct...

Researchers isolate protein domain linked to tumor progression

... Troy, N.Y. When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs). Now, resea...

Starfish strike at coral kingdom

...tails of how it will work and in particular, there is, as yet, no mention of the fundamental role of research in the conservation programme. We are disappointed that a comprehensive research programme is yet to be outlined in the CTI. The success of large marine parks, like the Great Barrier Reef Marine Park, ...

Starfish outbreak threatens corals

...ers say. However, there are few details of how it will work and no mention of the fundamental role of research in the conservation program. We are disappointed research is yet to be fully considered in the CTI. The success of large marine parks, like the Great Barrier Reef Marine Park, is largely due to the p...

1 person out of every 1,000 has synaesthesia, in which an individual can smell a sound

...naesthesia is the fact that people are certain about their perceptions: they feel that their way of experiencing the world is correct, and they become disappointed when they realize there is something that is not quite right. Therefore, when a person with grapheme-colour synaesthesia indicates that the word table...

Dakotas continue to yield paleontological treasures

...r a good deal of scientific research with its descriptions of territory acquired through the Louisiana Purchase. While Thomas Jefferson was said to be disappointed by the absence of living megafauna, the area ultimately yielded a wealth of Late Cretaceous fossils. A new volume published by the Geological Society ...

US-French research team to barcode an entire ecosystem

... species on Moorea, although that number may change as cryptic communities and organisms are sampled and genetic markers reveal novel species. "I'd be disappointed if we don't hit at least 10,000 species," said Meyer. The number of species on the 51-square-mile island of Moorea is small compared with that on l...

Marine scientists warn human safety, prosperity depend on better ocean observing system

...l, CoML program director for the Alfred P. Sloan Foundation: "2012 will be the centenary of the sinking of the Titanic. I think Captain Smith would be disappointed by the continuing hesitation to firm up our ocean observing system." ...

Human safety, prosperity depend on better ocean observing system: Scientists

...l, CoML program director for the Alfred P. Sloan Foundation: "2012 will be the centenary of the sinking of the Titanic. I think Captain Smith would be disappointed by the continuing hesitation to firm up our ocean observing system." ...

Protect patients from exploitation by alternative medicines industry

... if the patient is not cured, it is the patient who has failed, not the alternative therapy. The patient has let down the alternative practitioner and disappointed his family who have encouraged his “treatment.? As well as the complementary medicines they take, many patients will have changed their diets in o...

Disappointed in Biological Technology

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

...ngoing clinical trials and review available data. Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "We are obviously disappointed by the results and look forward to further announcements from BioMS and Lilly regarding their future plans for this approach to treating SPMS." ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...onduct a clinical program that could lead to approval in CAP," said Dr. Michael Flavin, Chairman and CEO of Advanced Life Sciences. "We are, however, disappointed that the timing of the new draft CAP guidance issuance had an unfortunate impact on the outcome of our NDA. Looking ahead, we intend to design a stud...

U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International

...n U.S. Federal District Court to challenge Thoratec's proposed acquisition of HeartWare International. Thoratec and HeartWare International are disappointed with the FTC's decision to challenge the acquisition. The companies intend to review the FTC's decision and mutually assess the appropriate next steps...

GPhA Calls Senate HELP Committee Action Disappointing for Countless Patients

...ent today from GPhA President and CEO Kathleen Jaeger on the Senate HELP Committee's vote on biogenerics legislation. "While we are extremely disappointed that the Committee action could result in patients having little or no access to affordable biogenerics, we will continue to fight in the House to ens...

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

...ative methods of assessing muscle function will be considered for the proposed trial. Dr. Melvin Sharoky, Insmed's Chairman, commented, "We are disappointed that this trial did not meet the majority of its functional endpoints. However, the statistically significant improvement in insulin sensitivity seen ...

CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement

... Dr. Brian McNamee, CEO and Managing Director of CSL Limited, said, "We are disappointed that the U.S. Federal Trade Commission (FTC) resolved to block the transact...ion of the merger agreement is in the best interest of all parties. We are disappointed that patients will not benefit from the efficiencies we saw in the proposed...

Onyx Pharmaceuticals Files Complaint Against Bayer Corporation

... counsel of Onyx, said, "Onyx and Bayer have had a long-standing and successful collaboration for more than 15 years. Against that background, we are disappointed that we could not resolve this matter and believe this complaint is necessary to protect our rights and the rights of our shareholders under the colla...

Amylin Comments on RiskMetrics Report

...oposed by Carl Icahn and Eastbourne Capital Management, L.L.C. We are confident that our slate of nominees is the right Board to lead Amylin. We are disappointed that RiskMetrics has recommended three dissident nominees to our annually-elected Board. The Company urges shareholders to vote FOR Amylin's highly-q...

Obama Budget Level Funds Career Technical Education

...onal Board reports. "It is refreshing that this Administration recognizes the need for an investment in career technical education, however I am disappointed that the President's budget proposes flat funding for Perkins," said Kimberly A. Green, executive director of the National Association of State Direct...

Neurocrine Announces Work Force Restructuring

...n its clinical programs and pre-clinical development leads. Following these reductions, Neurocrine will have approximately 60 employees. "We are disappointed that we have to make this painful decision that will have such an effect on so many of our employees and their families. Our employees have always sh...